The Union government has asked states and Union territories to review compliance with rules on displaying healthcare charges. Maharashtra has directed private medical establishments to publish their rates in Marathi and English. The aim is to help families anticipate expenditure and reduce billing disputes, although a rate card will not explain the total treatment cost or why each service is required.

Rating agency CRISIL expects private-hospital revenue to rise 14–15% in 2026–27, supported by additional capacity, healthy occupancy and a 5–7% increase in average revenue per occupied bed. Part of the latter reflects more complex, high-value treatment rather than price increases alone.

Reaching more patients, developing specialist capabilities and increasing expenditure per admission can all lift revenue, but their benefits to patients need separate scrutiny.

A hospital developing specialist services may treat difficult conditions that previously required patients to go elsewhere. Higher revenue per admission would then accompany additional investment, expertise and operating costs. Higher prices and more tests or procedures per admission can also raise hospital revenue, without necessarily improving patient care.

Calling it a “better treatment mix” does not show whether hospitals are treating more complex cases, or simply charging existing patients more. Higher occupancy does not establish better care. Hospitals can treat more patients by shortening stays. Comparing outcomes for similar patients and procedures, including complications and readmissions, would show whether care has improved. Hospital managements should therefore explain revenue growth through changes in patient numbers, treatment complexity, prices, and services delivered.

Acquisition Arithmetic
Global investors have spent about $10 billion buying stakes in Indian hospital chains over five years, according to EY data. Capital may have supported facilities and technology, but money spent on acquiring ownership is not a measure of additional capacity created.

Acquisitions can improve purchasing, management and access to specialists without immediately adding beds. Those gains need to be distinguished from the revenue brought into the group by the purchase itself. Lower procurement costs can fund more staff, new services, lower charges or higher margins. Hospitals must show whether patients benefit from them.

International research shows that lower operating costs do not always benefit patients. Since most of this research comes from outside India and has methodological limitations, it cannot establish the effects of Indian hospital acquisitions.

The national bed share of PE-backed hospitals says little about the choices facing a family seeking treatment nearby. The relevant question is whether local hospitals offer appropriate care at charges they can understand and question. Patients should not have to seek a differently owned hospital to secure those protections.

Patient Position
A family considering major treatment is poorly placed to negotiate over each component of the bill. Clinical uncertainty and the consequences of delay make a clear explanation of the proposed care more useful than a lengthy list of individual prices.

For planned admissions, that explanation should include expected benefits, relevant alternatives, package exclusions and circumstances that could materially change the estimate. It should also identify the insurer’s commitment and the patient’s possible liability before the expense is incurred, wherever practicable.

Hospitals and insurers disagree over the benefits and reimbursement of some advanced treatments. Neither a coverage refusal nor an authorisation settles the clinical merits, and patients should not be left to resolve that disagreement after treatment.

Capping selected charges may offer protection, but the relevant measure is the total bill. Savings on a medicine or device can be offset elsewhere, while a lower price cannot establish whether an intervention was necessary. Scrutiny must therefore cover the treatment episode, including its clinical justification and cost.

The acquisition model has already attracted parliamentary scrutiny, including recommendations to examine price caps, foreign-investment rules and a hospital regulator. While these are still recommendations, they highlight the importance of demonstrating the claimed benefits of consolidation.

How much of the projected 5–7% rise in revenue per occupied bed comes from more complex care, higher tariffs and additional services? Until those contributions are clear, “better treatment mix” leaves unanswered what patients receive for the extra money.